Peter D. O'Hanley
Corporate Officer/Principal bei Stanford University
Aktive Positionen von Peter D. O'Hanley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stanford University | Corporate Officer/Principal | 01.01.1985 | - |
Karriereverlauf von Peter D. O'Hanley
Ehemalige bekannte Positionen von Peter D. O'Hanley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2004 | 09.01.2009 |
| General Counsel | 01.03.2004 | 09.01.2009 | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | 01.01.2003 |
| Preventis, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.01.2003 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01.01.1998 | 01.01.2000 |
Ausbildung von Peter D. O'Hanley
| Pomona College | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
| Preventis, Inc. | |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
- Börse
- Insiders
- Peter D. O'Hanley
- Erfahrung
